R. Gullapalli

A formulation strategy for gamma secretase inhibitor ELND006, a BCS class II compound: development of a nanosuspension formulation with improved oral bioavailability and reduced food effects in dogs.

E. Merisko-Liversidge, G. Liversidge, G. Tonn, 2012, Journal of pharmaceutical sciences.

Influence of an optimized non-ionic emulsifier blend on properties of oil-in-water emulsions.

R. Gullapalli, B. B. Sheth, 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Effect of methylcellulose on the stability of oil-in-water emulsions: influence of the disperse phase

R. Gullapalli, B. B. Sheth, 1997 .

Extemporaneous preparation strategy for early phase clinical studies

Carolyn L. Mazzitelli, R. Gullapalli, C. Charriez, 2018, International journal of pharmaceutics.

Effect of methylcellulose on the stability of oil-in-water emulsions

R. Gullapalli, B. B. Sheth, 1996 .

Soft gelatin capsules (softgels).

R. Gullapalli, Rampurna Prasad Gullapalli, 2010, Journal of pharmaceutical sciences.

Polyethylene glycols in oral and parenteral formulations--A critical review.

Carolyn L. Mazzitelli, R. Gullapalli, 2015, International journal of pharmaceutics.

Gelatin and Non-Gelatin Capsule Dosage Forms.

Carolyn L. Mazzitelli, R. Gullapalli, 2017, Journal of pharmaceutical sciences.

Development of ALZET® osmotic pump compatible solvent compositions to solubilize poorly soluble compounds for preclinical studies

K. Quinn, R. Gullapalli, E. Goldbach, 2012, Drug delivery.